|Phone||+ 31 (0) 20 570 29 40|
Aescap Venture is a venture capital company investing in private medical companies in Europe.
Aescap invests in high-potential companies with realistic product opportunities and the potential to generate cashflow from licensing deals. This involves investments in all phases of development with an emphasis on earlier stages.
Aescap Ventureâ€™s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.
Aescap is an acronym for â€Accelerating European Science Companies and Productsâ€ and derived from Aesculapius - the Greek god of healthcare - and capital.
|Avantium Technologies||6/11||Venture Round||$43.9M||7|
|f-star Biotech||4/11||Venture Round||€15M||7|
|Aquapharm Biodiscovery||4/10||Series C||$6.4M||4|
|Avantium Technologies||10/08||Venture Round||$18M||4|
|Vivendy Therapeutics||1/08||Venture Round||$30.5M||2|
|f-star Biotech||9/07||Series A||€6M||2|
|Aquapharm Biodiscovery||7/07||Series B||£4M||5|
|ProtAffin Biotechnologie||5/07||Series A||€2.65M||2|